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Abstract
Venezuelan equine encephalitis viruses (VEEV) are responsible for human diseases in the Americas, producing severe or mild
illness with symptoms indistinguishable from dengue and other arboviral diseases. For this reason, many cases remain
without certain diagnosis. Seroprevalence studies for VEEV subtypes IAB, ID, IF (Mosso das Pedras virus; MDPV), IV (Pixuna
virus; PIXV) and VI (Rio Negro virus; RNV) were conducted in persons from Northern provinces of Argentina: Salta, Chaco and
Corrientes, using plaque reduction neutralization test (PRNT). RNV was detected in all studied provinces. Chaco presented
the highest prevalence of this virus (14.1%). Antibodies against VEEV IAB and -for the first time- against MDPV and PIXV
were also detected in Chaco province. In Corrientes, seroprevalence against RNV was 1.3% in the pediatric population,
indicating recent infections. In Salta, this was the first investigation of VEEV members, and antibodies against RNV and PIXV
were detected. These results provide evidence of circulation of many VEE viruses in Northern Argentina, showing that
surveillance of these infectious agents should be intensified.
Citation: Pisano MB, Oria G, Beskow G, Aguilar J, Konigheim B, et al. (2013) Venezuelan Equine Encephalitis Viruses (VEEV) in Argentina: Serological Evidence of
Human Infection. PLoS Negl Trop Dis 7(12): e2551. doi:10.1371/journal.pntd.0002551
Editor: Scott C. Weaver, University of Texas Medical Branch, United States of America
Received May 15, 2013; Accepted October 7, 2013; Published December 12, 2013
Copyright:  2013 Pisano et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by grants of CONICET-PIP (Consejo Nacional de Investigaciones Cientı´ficas y Te´cnicas), Bunge and Born Foundation (FBBEI11/
10), SECyT-National University of Co´rdoba and SGCyT-National University of Northeast. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: mbelenpisano@gmail.com
Introduction
Venezuelan equine encephalitis (VEE) is a reemerging mosqui-
to-borne viral disease that is severely debilitating and sometimes
fatal to humans [1]. The etiological agent, VEE virus (VEEV),
belongs to the VEE complex (Togaviridae: Alphavirus), one of the
major alphavirus serogroups found in the New World [2].
Members of the VEE complex are distributed throughout America
and have been originally classified in subtypes based on their
serology; however, they are now considered different virus species.
Only subtypes IAB and IC are considered epidemic/epizootic
varieties since they have been responsible for outbreaks involving
equine and human cases [3]. These subtypes undergo an
amplification cycle that involves equids, which develop high titer
viremia, and mosquitoes [1]. Enzootic strains (subtype I varieties
ID, IE, IF and subtypes II to VI) are not associated with equine
disease, producing low titer viremia, with the exception of VEEV
IE. Interestingly, strains in this subtype have been responsible for
epizootics in Mexico and appear to be equine neurovirulent, but
are not known to produce high titer viremia in equids [4].
Enzootic strains circulate in forested or swamp habitats, where
rodents serve as reservoir hosts and Culex mosquitoes -mainly in
the subgenus Melanoconion- act as vectors [5]. However, these
viruses have also been detected in urban areas [6,7,8]. Human
infection by any of these strains can be completely asymptomatic
or present with a mild disease, with symptoms similar to dengue or
influenza, although a fatal human case caused by enzootic VEEV
ID was reported in Panama in 1961 [1]. Enzootic VEEV are
increasingly recognized as important endemic pathogens of people
who live near the enzootic transmission foci and/or enter the
habitats where enzootic circulation occurs [1]. Some of these
enzootic viruses are postulated to be progenitors of epizootic
strains [4].
In Argentina, the circulation of Rio Negro Virus (VEEV
subtype VI; RNV) is well known; it was isolated for the first time in
1980 by Mitchell et al. from mosquitoes of Chaco province [9]. In
1989, Contigiani et al. reported an outbreak of acute febrile illness
in humans from General Belgrano Island (Formosa province)
associated to RNV, with symptoms indistinguishable from dengue
[10]. Subsequent serological studies carried out in the same area
showed the presence of human antibodies not only against RNV,
but also against subtype IAB (TC83 vaccine strain) [11]. Recent
investigations have reported the molecular detection of RNV and
Pixuna Virus (VEEV subtype IV; PIXV) in Chaco and Tucuma´n
provinces [7,8], demonstrating that more than one VEEV is
currently active in Argentina. RNV has also been detected in
Co´rdoba Province [12].
Because epidemics of arboviruses often receive notice only when
they are acute and massive, the public loses sight of ongoing
transmission, which has a significant daily impact on the life of
people living in endemic countries. These diseases are often
ignored and neglected because they have not yet impacted the
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lives of those living in affluent areas. They are understudied and go
unnoticed until outbreaks occur [13]. The epidemiological
characteristics and geographic range for many endemic arbovi-
ruses in South America are poorly understood [14]. This is the
case for endemic VEE, which is underreported in many parts of
the continent, where enzootic circulation occurs and surveillance
of febrile illness is limited, such as in Argentina. To begin to
address this gap, we proposed to determine the occurrence of
VEEV infection in humans of the North part of the country -
where circulation of RNV and PIXV is well known-, and
investigated the presence of neutralizing antibodies (NTAbs)
against VEEV IAB, VEEV ID, Mosso das Pedras virus (VEEV
subtype IF; MDPV), PIXV and RNV in human sera obtained
during the period 2006–2011.
Materials and Methods
Ethics statement
This study was designed as a non-associated, anonymous
survey: data registered were only number of sample, date of
sampling, age of the patient (years), gender and address (street and
neighborhood). It was approved by the ethics committee of the
Faculty of Medicine, National University of Northeast (UNNE)
and conducted within the project NuFBBI11/10.
Sites and samples analyzed
All the studied locations are indicated in Figure 1. The sera
were obtained from people without symptoms who attended
health centers to perform routine or other analysis within the
project ‘‘Ecoepidemiology of arboviruses in Argentina’’.
Chaco Province. we studied 294 serum samples of people
aged between 2 and 88 years: 172 obtained in the Central
Laboratory of Chaco Province, located in the capital city of
Resistencia (27u279760S; 58u599790W), from March to July 2007;
and 122 from Pampa del Indio (26u029540S; 59u569320W),
obtained in the Dante Tardelli Hospital between December
2010 and May 2011.
Chaco Province is characterized by a very large plain with
smooth slopes towards the southeast. The climate is subtropical
with a dry season. The eastern woodland of the province, where
this study was conducted, is within a flood plain with imperfect or
poor drainage. The soil permeability is moderately slow, which
allows the formation of flooding areas [15]. The mean annual
temperature is 23uC and the mean rainfall is 1280 mm. The rainy
season is between November–April, with peaks of rainfall in
spring (September–October) and autumn (March–April) [15].
Resistencia is the capital city of the Province, located at the banks
of Parana´ River (Figure 1). Pampa del Indio is a location near the
Provincial Park of the same name (30 km far), in which is the
Bermejo River (Figure 1).
Corrientes Province. 149 serum samples from individuals
aged 0 to 20 years were investigated. These samples were obtained
in the Juan Pablo II Pediatric Hospital, located in Corrientes city
(27u289160S; 58u509220W), capital of the province, from Decem-
ber 2006 to April 2007.
In Corrientes, three phytogeographical zones converge. Due to
its location, there are three climatic zones: humid subtropical in the
Northeast of the province, subtropical with dry season towards the
middle Parana´ and temperate with rainfall throughout the year in
the Southern. The mean annual temperature is 21uC and the mean
rainfall is 1450 mm [16]. The city of Corrientes is located in the
other side of the Parana´ River, in front of Resistencia city (Figure 1).
Salta Province. 195 human serum samples aged 1 to 78
years were studied. They were obtained in the San Vicente de Paul
Hospital, from Ora´n city (23u089190S; 64u199060W), during 2009.
Salta Province has an extremely varied relief, from the peaks of
Los Andes to the plains of Chaco, which determines the presence
of different types of climate and well contrasted environments. The
mean annual temperature is 18uC and the mean rainfall is
400 mm. In Ora´n, the climate is subtropical of the highlands, with
a mean temperature of 22uC [17].
Plaque reduction neutralization test (PRNT)
Sera were inactivated at 56uC during 25 minutes, then
centrifuged at 11.400 g for 30 minutes to clarify; the supernatant
was stored at 220uC until assayed. Samples were analyzed for
NTAb’s against VEEV subtypes IAB, ID, IF, IV and VI by PRNT
using Vero cells as described by Early et al. (1967) [18]. Serum
samples were initially tested at a dilution of 1:10. Those that
neutralized at least 80% of inoculated viral plaque forming units
(pfu) were considered positive, and in order to determine the end-
point titer, they were further titrated with the same technique,
using 2-fold serial dilutions.
Viruses used in this study were: a) VEEV IAB strain TC83 [19],
b) VEEV ID strain 3880 -isolated for the first time in 1961 in
Panama- [2], c) MDPV (VEEV subtype IF) strain 78V3531 -first
isolated in 1978 in Brazil- [2], d) PIXV (VEEV subtype IV) strain
BeAr35645 [20], and e) RNV (VEEV subtype VI) strain AG80-
663 [9]. Viral suspensions were prepared with a 10% dilution of
infected suckling mice brain in Minimum Essential Medium
(MEM) 10% fetal bovine serum (FBS) and 1% antibiotics
(gentamicin), centrifuged at 11.400 g for 30 minutes.
Results
Seroprevalence in Chaco Province
March-May, 2007. The 172 serum samples collected during
this period were tested against VEEV subtype IAB, PIXV and
RNV. These viruses were selected based on history of previous
VEEV circulation in the region: detection of NTAbs against
VEEV subtype I and RNV in birds, horses and rodents [21], and
molecular detection of PIXV and RNV in mosquitoes [7].
Twenty three samples showed VEEV complex neutralization.
Sixteen of them corresponded to inhabitants of Resistencia city
and 7 to individuals of other localities of the province (Table 1).
All 23 VEEV complex reactive samples were specific to RNV; 6
of them showed monotypic reactions (Table 1). The remaining
samples exhibited serological profiles compatible with hetero-
typical serological response, since they resulted positive to PIXV,
Author Summary
Venezuelan equine encephalitis viruses (VEEV) are respon-
sible for human diseases in the Americas. They produce
severe or mild illnesses with symptoms indistinguishable
from dengue and other arboviral diseases; for this reason,
many cases remain undiagnosed. We detected neutralizing
antibodies (NTAbs) against VEEV IAB, VEEV ID, MDPV (VEEV
subtype IF), PIXV (VEEV subtype IV) and RNV (VEEV subtype
VI) in human serum samples of Northern provinces of
Argentina. Chaco province showed presence of NTAbs
against VEEV IAB, MDPV, PIXV and RNV. In Corrientes
province, we detected NTAbs against RNV in a pediatric
population. NTAbs against PIXV and RNV were also
detected in Salta province. These findings demonstrated
the circulation of many VEEV strains in Northern Argentina
and underscore the need for surveillance of dengue like
illness in this region.
Seroprevalence of VEEV in Argentina
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VEEV IAB, or both of them. According to the guidelines of the
Center for Disease Control and Prevention, a titer difference of
four-fold or grater is used to identify the etiologic agent; when a
four-fold difference is not observed, the specific etiologic agent
cannot be defined [22]. Furthermore, previous studies carried out
by Ca´mara et al. (1997) had shown cross reactions between some
subtypes in one or both directions by PRNT (Table 2) [23], which
should be considered in the interpretation of results.
The analysis of the results showed that titers against RNV were,
in all cases, 4 times or greater than titers against PIXV, suggesting
that the infecting agent had been RNV. Thus, seroprevalence for
this virus in Chaco in 2007 was 14.1%. Analyzing data only from
Resistencia, indicated that its seroprevalence was 10.5% in this
city. Prevalence of VEEV subtype IAB and PIXV could not be
calculated because of cross reactivity.
December 2010–May 2011. Samples collected in Pampa del
Indio were tested against VEEV subtype IAB, MDPV, PIXV and
RNV. Previous investigations carried out by Monath et al. (1985)
[21] in Northern areas of Argentina had postulated that positive
samples against subtype IAB obtained in rodents would have been
due to the presence of an enzootic variety of subtype I. For this
reason, in this investigation, we also included MDPV, which
circulates in Southern areas of the neighbor country of Brazil.
Forty two out of the 122 samples analyzed resulted positive
against some of the members of the VEE complex (Table 3). The
age range of the patients was 15–88 years.
Most of the samples analyzed tested positive against more than
one virus, suggesting the existence of cross reactivity. Only a few
samples had NTAbs against one virus: sample 53 was only positive
against MDPV, sample 66 only against VEEV IAB, and samples
78, 94, 99, 104, 110 and 116 only against RNV (Table 3). Among
samples that tested reactive against more than one virus, a number
of them presented a titer difference higher than four-fold, pointing
out which was the infecting virus. Other samples did not show a
Figure 1. Map of Argentina. Provinces evaluated in this study and provinces where VEEVs have previously been detected.
doi:10.1371/journal.pntd.0002551.g001
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four-fold titer difference, making it difficult to determine whether
these individuals had been infected with one or more VEEV.
Seroprevalence of RNV was 23.0%. This value may be
underestimated since the samples that could reflect double or
triple infections (with titer differences lower than 4 times) were not
included in this calculation.
Seroprevalence in Corrientes Province
The 149 specimens analyzed were obtained from patients aged
0–20 years old. They were tested against VEEV subtype IAB and
RNV. Two of them presented NTAbs against both RNV and
TC83 strain, and only 1 tested positive against RNV (Table 4).
Sample 313 corresponded to a resident of Chaco Province, for this
reason, it was excluded of the analysis. The other 2 positive
samples belonged to patients who lived in Corrientes city.
Seroprevalence of RNV in pediatric population was 1.3%.
Seroprevalence in Salta Province
The 197 serum samples from Ora´n (Salta) were tested against
VEEV ID, PIXV and RNV. The last two viruses were included
because of previous reports about their molecular detection in
other Northern regions. Subtype ID was included due to its recent
detection in Bolivia (bordering country in Salta province)
(Figure 1), where it has been associated with human disease with
symptoms similar to dengue [6].
Five samples tested positive (age range: 21–67 years, Table 5).
One specimen presented NTAbs only against RNV (sample 422);
the others presented NTAbs against both RNV and PIXV, with
titers varying in favor of one or the other virus. Sample 419
showed titer of NTAbs against PIXV 4 times greater, determining
that this was the infecting virus; sample 619 presented a greater
difference in favor of RNV (16 times). Titers obtained in samples
234 and 413 showed no significant differences (Table 5).
Neutralizing antibodies against VEEV ID were not detected.
Discussion
Over the past few decades, a global resurgence of arboviruses
has been detected worldwide [16]. Despite the public health
relevance, the geographic range, relative impact and epidemio-
logic characteristics associated with arbovirus infection are poorly
described in many regions of America, including Argentina.
Surveillance plays an important role in the prevention of these
diseases -particularly VEE-, knowing circulating viral species,
susceptible population and epidemiology. Within this surveillance,
studies of serological prevalence have served for a long time -and
are still useful- to indicate immune status of a given population
against an infectious agent, providing information of its circulation
in a region. For arboviruses, PRNT is the gold standard technique
due to its high sensitivity and specificity. In Argentina, there is
serological evidence of the presence of VEEV since 1950’s decade
in humans and rodents [24,21,11]. Our studies detected current
VEEV activity in the North part of the country.
Chaco Province
In Chaco Province prevalence for RNV was high. Detections of
this virus in individuals aged 3–5 years provide evidence of its
recent circulation. Titers of NTAbs obtained in the period 2007
were, in many cases, very high (.640 and 1280), agreeing with
secondary infections. In Pampa del Indio -where there are no prior
registers of VEEV circulation- titers obtained against RNV
showed profiles compatible with primary infections (only one
sample presented titer .640). This could suggest that Pampa del
Indio is an area of more recent circulation of RNV, compared to
other places of Chaco province, like Resistencia city.
This is the first search of antibodies against PIXV in our
country, with positive results in samples from Chaco in both
Table 1. Positive samples for antibody detection against
VEEV IAB, PIXV (IV) and RNV (VI) in humans from Chaco
province and their titers during 2007.
Virus
Sample
N6 VEEV-IAB RNV PIXV Age1 Sex2 Place
41 2 + ($640) + (20) 20 F Cap. Solari
43 2 + (40) 2 3 F R3
44 + (20) + (320) + (20) 20 F R
51 2 + (40) 2 21 F R
99 2 + (160) 2 5 M R
194 2 + (80) 2 19 F R
290 + (80) + (2560) + (160) 14 M R
295 + (80) + (2560) + (160) 21 F Cap. Solari
344 2 + (160) 2 17 F R
369 + (80) + (1280) + (80) 21 F R
382 + (20) + (.640) + (80) 26 F R
395 + (10) + (320) + (80) 38 M R
408 + (10) + (640) + (80) 38 F R
432 + (10) + (.640) 2 28 M Fontana
444 2 + (640) + (10) 23 M R
460 + (40) + (640) + (40) 41 M Fontana
474 2 + (.640) 2 52 F R
485 2 + (80) 2 51 F Fontana
524 + (20) + (640) + (40) 23 F El Sauzalito
541 + (40) + (.640) + (20) 32 M R
555 + (20) + (320) + (20) 29 F R
567 + (20) + (160) + (20) 30 M R
570 + (20) + (.640) + (10) 26 F Barranqueras
+: positive; 2: negative.
1Age (years):
2F: female; M: male.
3R: Resistencia.
doi:10.1371/journal.pntd.0002551.t001
Table 2. Cross reactions between VEEV IAB, VEEV ID, MDPV
(IF), PIXV (IV) and RNV (VI) by PRNT (15).
Mouse immune ascitic fluid against:
Virus/Subtype VEEV-IAB VEEV-ID MDPV-IF PIXV-IV RNV-VI
VEEV-IAB + 2 2 +/2 2
VEEV-ID 2 + 2 2 2
MDPV-IF +/2 +/2 + +/2 2
PIXV-IV +/2 2 2 + +/2
RNV-VI 2 +/2 2 +/2 +
+: Titer $320.
+/2: Titer between 10 and 40.
2: Titer ,10.
doi:10.1371/journal.pntd.0002551.t002
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studied periods. Some of these positive samples could be
consequence of a serological cross reaction with RNV, while
others could represent true positive results. In 2007, despite the
fact that the titers obtained against RNV were four-fold higher
than those obtained against PIXV and VEEV IAB, we cannot
discard that, as it has been documented for some flaviviruses [22],
the observed heterotypic immunological response could be the
result of sequential infections by PIXV and/or VEEV IAB,
especially in those samples in which the titers against PIXV were
of 80 or more. For this reason, some of these individuals may have
suffered infection by two or more viruses. Samples with similar
titers of NTAbs against PIXV and another virus may correspond
to double or triple infections, positioning Chaco province as a
hyper endemic area. Pixuna virus infections are supported by
previously reported molecular detections of this virus in the same
region [7]. Detection of NTAbs against PIXV in Pampa del Indio
represents not only another evidence of its presence in Chaco
province (and Argentina), but also the wide distribution of this
virus in our country.
We can assume that VEEV IAB positive specimens might be the
result of antigenic cross reactivity with PIXV (in many cases titers
against PIXV were 4 times greater than against VEEV IAB);
however, results obtained with sample 432 in 2007 (Table 1) and
sample 66 in 2011 (Table 3) could indicate activity of subtype I,
since it was demonstrated that VEEV IAB does not present
serological cross reactivity with RNV. This should be considered
cautiously, since there is no evidence of epidemic/epizootic viral
activity in our region, but the circulation of an enzootic variety of
other subtype I might exist. This hypothesis was first proposed by
Monath in 1985, and is supported by previous detections of
Table 3. Positive samples for detection of neutralizing Abs
against VEEV IAB, MDPV (IF), PIXV (IV) and RNV (VI), and their
titers in Pampa del Indio (Chaco Province) in the period
December 2010–May 2011.
Virus
Sample N6 VEEV-IAB MDPV RNV PIXV Sex1
2 2 + (20) + (20) + (10) F
3 + (20) 2 + (80) + (20) M
6 2 + (40) + (80) + (20) F
8 2 + (10) + (20) + (10) F
9 2 + (20) + (40) + (10) F
10 2 + (10) + (80) + (10) F
16 + (20) + (20) + (40) + (40) F
17 2 + (40) + (40) + (10) M
18 2 + (10) + (80) + (10) M
23 2 + (20) + (20) 2 F
25 2 + (10) + (40) + (10) M
26 2 + (40) + (160) + (10) F
27 2 + (20) + (20) + (10) M
28 2 + (20) + (160) + (20) F
31 2 + (20) + (20) + (20) M
33 + (20) + (80) + (160) + (40) F
37 2 2 + (40) + (20) F
51 2 + (20) 2 + (10) F
53 2 + (20) 2 2 M
57 2 + (20) + (20) 2 F
59 + (10) + (20) + (80) + (10) F
61 + (10) + (40) 2 + (40) F
63 + (10) + (20) + (80) + (20) F
66 + (10) 2 2 2 M
78 2 2 + (40) 2 F
80 + (80) + (.320) + (320) + (80) M
81 + (20) + (80) 2 + (20) M
85 + (20) + (80) + (20) 2 M
86 + (20) + (20) + (640) + (40) F
87 + (10) + (10) 2 + (10) M
90 + (10) + (80) 2 + (40) F
93 + (20) + (40) 2 2 M
94 2 2 + (80) 2 M
95 + (10) + (40) + (160) 2 M
99 2 2 + (160) 2 M
104 2 2 + (320) 2 F
109 2 + (40) + (80) + (20) F
110 2 2 + (160) 2 F
112 + (10) + (20) + (.640) 2 F
115 2 + (20) + (160) + (20) M
116 2 2 + (80) 2 F
123 2 2 + (40) + (10) F
+: positive; 2: negative.
1F: female; M: male.
doi:10.1371/journal.pntd.0002551.t003
Table 4. Positive serum samples against VEEV IAB and RNV
(VI) by PRNT from Corrientes Province obtained of pediatric
patients (0–20 years old) between December 2006 and April
2007.
Virus
Sample N6 VEEV-IAB RNV Age (years) Sex1 Place
197 2 + (10) 8 M Corrientes
313 + (20) + ($640) 12 F Chaco
326 + (10) + ($640) 10 M Corrientes
+: positive 2: negative.
1F: female; M: male.
doi:10.1371/journal.pntd.0002551.t004
Table 5. Detections of VEEV ID, PIXV (IV) and RNV (VI) by
PRNT in samples from Ora´n, Salta Province, in 2009.
Virus
Sample N6 RNV PIXV VEEV-ID Sex1 Age (years)
234 + (80) + (40) 2 M 67
413 + (10) + (20) 2 F 32
419 + (20) + (80) 2 M 48
422 + (40) 2 2 F 21
619 + (160) + (10) 2 M 49
+: positive. 2: negative.
1F: female; M: male.
doi:10.1371/journal.pntd.0002551.t005
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antibodies against VEEV IAB in animals during the 80’s [21] and
in humans in 1991 [11], although no isolations of members of this
subtype have been reported up to date. This leaves an open door
to suspect that these antibodies previously detected could
correspond to antibodies against PIXV captured by TC83 strain
in the PRNT.
Many of the samples analyzed in Pampa del Indio had a positive
result to MDPV. Some of them could be due to serological cross
reactions with VEEV IAB and PIXV, since MDPV captures
NTAbs generated against these viruses [23]. Other specimens
presented titers against MDPV that were equal or higher than
other viruses. These cases could represent evidence of MDPV
circulation in Pampa del Indio and for the first time, in Argentina.
This should be considered cautiously because, as we previously
mentioned, there are no molecular detections of this or other
enzootic subtype I in this country. Further studies with emphasis
on the search of MDPV (or other enzootic VEEV subtype I) are
needed, both by molecular detection as well as by surveillance of
undifferentiated febrile human cases.
Corrientes Province
In Corrientes, the prevalence of 1.3% for RNV in a pediatric
population indicates recent circulation of the virus. The low value
may show less viral activity in this city compared to Chaco (with a
prevalence of 14.1% in 2009) or could be due to the fact that the
detections were made in a pediatric population; this percentage
may be higher in the adult or general population. The high titer of
NTAbs against RNV observed in sample 326 ($640), could
indicate current infection. Our results demonstrate that VEEV
strains have a silent and endemic circulation in this area and
highlight the need of constant surveillance.
Salta Province
This is the first investigation of VEEV in Salta Province. Four
out of the 5 positive results exhibited serological profiles
compatible with a heterotypic serological response. In two of
them RNV appears to be the infecting virus, and in one PIXV. In
the other two samples it was impossible to determine the etiologic
agent. All positive samples were obtained from adult patients, and
in consequence, it was not possible to define whether they were
recent infections or not. These are the first detections of RNV and
PIXV in Salta Province, showing the wide distribution of these
viruses in Northern Argentina. In Ora´n city, some outbreaks of
other arboviruses such as DENV, which share symptoms with
RNV, have occurred. Previous reports in other countries of
America have shown a sub-estimation of VEEV cases in regions
with co-circulation with DENV or other arboviruses [4]. As this
could be the case of Ora´n city, it is relevant to acknowledge the
circulation of VEEVs in this area and in all the province,
emphasizing the investigation of acute febrile cases reported as
probable dengue. The fact that all the samples tested negative
against VEEV ID indicates no presence of this virus in our country
so far. However, since intense commercial activity is developed
between Argentina and Bolivia in this area, the introduction of
VEEV ID in our territory should not be discarded; therefore,
surveillance should be active in this region with the aim to detect
cases early.
These serological findings lead us to postulate the hypothesis
that RNV is expanding into new regions, probably due to climate
changes -since the climate may influence the ecology of microbial
systems [25] -as well as to an increase in the commercial activities
of the area. They also constitute an evidence of enzootic VEEV
circulation in Northern regions of Argentina, although the role of
these viruses in the production of human diseases and their impact
on public health is still unknown. While detections of VEEV
NTAbs in our study all belong to enzootic types, genetic studies
have demonstrated that enzootic and epizootic subtypes are closely
related, and a modest number of nucleotide changes can alter the
viral phenotype dramatically, converting an enzootic strain to an
epizootic strain [14,26]. For this reason, it is important to perform
complementary molecular studies in order to provide information
about the variability of local VEEV strains.
This report is an approach to recognize which VEEV strains
circulate in Northern areas of Argentina. In light of the lack of a
distinctive clinical presentation and the diversity of the etiologic
agents circulating in the studied area, more investigations that
focus on arboviral transmission patterns, phylogenetic relation-
ships between the strains and occurrence of clinical cases produced
by RNV and a potential VEEV subtype I virus, are needed to
achieve a better understanding of the impact of these viruses on
human health.
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